Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Geriatrics | Internal Medicine | Nursing | Pharmacy | Journal

Back to Journal Articles

Seniors Overspending on Prescription Drug Plans

Last Updated: October 12, 2012.

 

Medicare Part D beneficiaries overspend by hundreds per year due to difficulty selecting plan

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Recipients of Medicare Part D benefits have difficulty selecting the most cost-effective plan to cover their medication needs and, consequently, overpay by an average of $368 per year, with one-fifth overspending by $500 or more per year, according to research published in the October issue of Health Affairs.

FRIDAY, Oct. 12 (HealthDay News) -- Recipients of Medicare Part D benefits have difficulty selecting the most cost-effective plan to cover their medication needs and, consequently, overpay by an average of $368 per year, with one-fifth overspending by $500 or more per year, according to research published in the October issue of Health Affairs.

Chao Zhou, Ph.D., and Yuting Zhang, Ph.D., of the University of Pittsburgh, conducted a study using 2009 Medicare Part D data to determine whether seniors were able to choose the most cost-effective plan for themselves from among the dozens of competing plans.

The researchers found that only 5.2 percent of beneficiaries chose the cheapest plan. On average, Medicare Part D beneficiaries spent $368 more per year than necessary, based on their medication needs. A substantial percentage (22 percent) spent $500 or more per year above what was necessary. Many overspent on plan premiums for unneeded features such as generic drug coverage.

"People need assistance in choosing the least expensive plan for their medical needs," Zhou said in a statement. "Educational programs that help people navigate the dozens of plans available would make it easier to select plans that best meet their health care needs without overspending."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Filaggrin Mutations Up Risk of Irritant Contact Dermatitis Next: Abraxane Approved to Treat Advanced Lung Cancer

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.